Product Name |
Pramipexole D5 |
Alternate Names |
Pramipexole Stable Isotopes, Stable Isotopes of Pramipexole |
CAT No. |
CS-O-06876
|
CAS No. |
1217975-28-4 |
Category |
Stable Isotopes |
Stock |
IN-Stock
|
Mol. Wt. |
216.36 g/mol |
Mol. For. |
C₁₀H₁₂D₅N₃S
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Pramipexole |
Therapeutic |
Anti-Parkinsons |
Smileys |
NC1=NC(CC[C@H](NCC([2H])([2H])C([2H])([2H])[2H])C2)=C2S1 |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Pramipexole D5 is a neuroactive drug that belongs to the class of dopamine receptor agonists. It is commonly used in the treatment of Parkinson's disease and restless leg syndrome. Pramipexole D5 is classified as a non-ergoline dopamine agonist, which means that it has a high selectivity for dopamine D2 and D3 receptors. This selectivity allows for a more targeted effect on the dopamine system, which can help to reduce the side effects associated with other dopamine agonists.
The chemical structure of Pramipexole D5 is similar to dopamine, which allows it to bind to and activate dopamine receptors in the brain. This activation leads to an increase in dopamine levels, which can improve motor function and reduce symptoms of Parkinson's disease. Pramipexole D5 has also been shown to have neuroprotective properties, which means that it may help to slow the progression of Parkinson's disease.
The recommended dosage of Pramipexole D5 varies depending on the condition being treated and the individual patient. It is typically taken orally and can be administered once or twice daily. Like all medications, Pramipexole D5 can cause side effects, including nausea, dizziness, and fatigue. Patients should always consult with their healthcare provider before starting or stopping any medication.